Home/Filings/4/0001461959-18-000002
4//SEC Filing

Rosenstadt William S 4

Accession 0001461959-18-000002

CIK 0001596062other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 6:20 PM ET

Size

12.4 KB

Accession

0001461959-18-000002

Insider Transaction Report

Form 4
Period: 2017-06-05
Rosenstadt William S
DirectorGeneral Counsel10% Owner
Transactions
  • Award

    Incentive Stock Options

    2018-05-31+50,0001,000,000 total
    Exercise: $3.35Exp: 2023-05-31Common Stock (50,000 underlying)
  • Award

    Incentive Stock Options

    2018-05-31+100,0001,100,000 total
    Exercise: $3.35Exp: 2023-05-31Common Stock (100,000 underlying)
  • Award

    Incentive Stock Options

    2017-06-05+12,500925,000 total
    Exercise: $4.00From: 2018-06-05Exp: 2022-06-05Common Stock (12,500 underlying)
  • Award

    Incentive Stock Options

    2017-06-05+25,000950,000 total
    Exercise: $4.00From: 2018-06-05Exp: 2022-06-05Common Stock (25,000 underlying)
Footnotes (4)
  • [F1]Issued for director services.
  • [F2]Issued for officer services.
  • [F3]These options vest in 4 equal quarterly installments of 12,500 each, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. The first installment vested on May 31, 2018.
  • [F4]These options vest in 4 equal quarterly installments of 25,000 each, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. The first installment vested on May 31, 2018.

Issuer

Q BioMed Inc.

CIK 0001596062

Entity typeother

Related Parties

1
  • filerCIK 0001461959

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 6:20 PM ET
Size
12.4 KB